MGTX - Utang jangka cendhak marang modal MeiraGTx Holdings plc

Logo grafis MeiraGTx (MGTX)

The price action of MeiraGTx Holdings plc (MGTX) reflects the financial standing of a brand recognized as a leader in developing precision gene control systems, where the current metric stands at 0.00. MeiraGTx Holdings plc (MGTX) protects its position through alliances with pharma behemoths, which shields profits from market pressure. The development strategy relies on the synergy of management's scientific expertise and the ability to interact effectively with global corporations to mitigate operational risks.

Rasio utang jangka cendhak marang ekuitas: MeiraGTx Holdings (MGTX) kanggo 04.07.2022 - 01.11.2026
Produk merek MeiraGTx

This metric reflects the sensitivity of operating cash flow to short-term liabilities, identifying the risk of liquidity degradation as loans grow relative to equity. For MeiraGTx Holdings plc (MGTX), with its stable management and support from pharma behemoths, the chart of the short-term loan-to-equity ratio serves as an indicator of how effectively clinical trials are funded without the threat of a sharp share price markdown.

Analisis perusahaan pesaing

Utang jangka cendhak marang ekuitas Tempus AI (TEM)|Qiagen Corp - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang modal IONS (Ionis Pharmaceuticals)|Utang jangka cendhak marang modal repligen.com RGEN|RNA - Utang jangka cendhak marang ekuitas|CRISPR Therapeutics Inc (CRSP) - Rasio utang jangka cendhak marang ekuitas|WGS: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Ultragenyx Corp (RARE)|BEAM (Beam Therapeutics Inc.) - Utang jangka cendhak marang modal|sarepta.com (SRPT) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Twist Bioscience, Inc. (TWST)|TXG (10x Genomics Inc) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal NTLA (Intellia)|Utang jangka cendhak marang modal Stoke Corp STOK|BioLife Solutions, Inc. - Utang jangka cendhak marang modal|Tanggungan utang jangka cendhak marang ekuitas wavelifesciences.com (WVE)|MAZE (Maze Therapeutics) - Rasio utang jangka cendhak marang ekuitas|SION: Rasio silihan jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas PRME|Rasio utang jangka cendhak marang modal TSHA (Taysha Corp)|Rasio utang jangka cendhak marang ekuitas QURE (uniQure N.V.)|RGNX (regenxbio.com) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal SLDB (Solid Biosciences)|Rasio tanggungan utang jangka cendhak marang modal OCGN|PACB - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Benitec Corp|Design Therapeutics (DSGN) - Utang jangka cendhak marang ekuitas|RCKT (rocketpharma.com) - Utang jangka cendhak marang ekuitas|FDMT (4D Molecular Therapeutics, Inc.) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang modal LXEO (Lexeo)|Utang jangka cendhak marang modal KRRO|Koefisien utang jangka cendhak marang modal Editas Corp|Utang jangka cendhak marang ekuitas Silence Therapeutics SLN|PRQR: Rasio utang jangka cendhak marang modal|Codexis Bio - Utang jangka cendhak marang modal|Tanggungan utang jangka cendhak marang ekuitas Sangamo Therapeutics Inc. (SGMO)|nautilus.bio (NAUT) - Utang jangka cendhak marang ekuitas|MGX - Koefisien utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas DTIL|GBIO: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Boundless Bio (BOLD)|XCUR: Kewajiban jangka cendhak marang ekuitas|Utang jangka cendhak marang ekuitas Imunon IMNN|Phio Pharmaceuticals Corp - Utang jangka cendhak marang ekuitas|Mustang Bio Corp - Utang jangka cendhak marang modal|TransCode Therapeutics (RNAZ) - Rasio utang jangka cendhak marang ekuitas|bionanogenomics.com (BNGO) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Applied DNA Sciences Inc|BLUE (Bluebird Bio) - Utang jangka cendhak marang modal|IPA - Tanggungan utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas OMGA (Omega Therapeutics)|Rasio silihan jangka cendhak marang modal OMIC|Regulus Therapeutics Inc. - Rasio utang jangka cendhak marang ekuitas|SYRS: Rasio utang jangka cendhak marang modal|Codex DNA - Utang jangka cendhak marang modal|TCON (TRACON Pharmaceuticals, Inc) - Rasio utang jangka cendhak marang modal|Unity Biotechnology (UBX) - Utang jangka cendhak marang ekuitas